Oh A new study These mice show that psychedelics make the brain more prone to “see” images from memory relatively than what's right in front of it.
Long before modern laboratory testing, indigenous cultures used these substances to treat psychological and physical ailments. gave The Aztecs used Psilocybin. Mushrooms as medicine, while Andean cults ate mescaline-rich San Pedro cacti hundreds of years ago. Archaeologists have found one Ritual bundle A cave in Bolivia hundreds of years old comprises traces of DMT (a robust hallucinogenic present in plants). They also found 5,000-year-old peyote buttons from Texas.
Modern travel began when the Swiss chemist Albert Hoffmann Synthesized LSD In 1938 1970s and 80sthe researchers found that these drugs bind to a particular receptor within the brain (called 5-HT2A) that may trigger hallucinations. This receptor is an element of the serotonin system, which affects mood and may affect anxiety and depression.
Fast forwarding to today, Discussion of scientists Whether psychedelic travel itself (mystical experience) is crucial. Treatment conditions Like depression and anxiety. Some scientists imagine that the actual good thing about psychedelics comes from their ability to assist brain cells rewire and communicate in recent ways—a process called neuroplasticity. It is feasible that hallucinations are only a side effect of their therapeutic effect.
Therefore, it is vital to grasp how these substances change people's perception. Moving towards trends in modern pharmacology. Drug design The goal is to induce a therapeutic “trip” of hallucinogens without unintended effects.
i A new studyscientists used mice to engineer certain brain cells to light up when activated. The higher the brightness, the more lively the cells were.
Technologies developed by considered one of the study's lead researchers, Thomas Knopfallowed the researchers to record each increases and reduces in voltage on the surface of the brain. These changes in voltage rely upon which cells are being activated for specific tasks.
During the experiment, rats were shown visual stimuli, similar to moving black and white bar patterns, in addition to a plain blank screen. This allowed the researchers to measure brain activity during each stimulus viewing and resting states.
Halfway through the experiment, the researchers injected the mice with a robust chemical that prompts the 5-HT2A serotonin receptor like LSD and psilocybin, but in a more selective and controlled way.
Black Day/Shutterstock
The researchers compared the brain's voltage patterns before and after the drug took effect, which helped them discover the neural circuits affected by psychedelics. They focused on the brain's primary visual cortex and focused on slow rhythmic oscillations (called theta rhythms) related to attention, memory consolidation and stimulus familiarity. High-resolution recordings revealed an interesting change in brain communication.
Before drugs, visual cortex output 5-Hz brain oscillations. Theta rhythm oscillations after psychedelic administration. Significantly fasterincreasing each strength and duration.
More importantly, these low-frequency waves synchronize with the visual processing areas of the brain. retrosplenial cortexwhich is involved in encoding, storing and retrieving memories. That synchronization was delayed by about 18 milliseconds, in line with him A traveling wave Activity connecting the 2 regions.
The psychedelic worked like a switch: He made it wet The brain's response to what the eyes were seeing allows the brain to “fill in” the missing visuals from its memory by increasing connections with memory areas.
Instead of counting on what was actually in front of the eyes, the mind began to place in pieces from its internal memory banks. This finding provides a proof for the way visual hallucinations may fit.
Lead researcher, Dirk Jancki, Described this condition is remarkably much like partial dreaming. Under the influence of medicine, the mind's internal imagery overrides external reality, making a vivid, self-created world.
Despite these insights, the study has limitations. As the authors acknowledge, among the results may reflect attentional bias from repeated images of rats. Mice and humans share several basic characteristics. Organization of the brainhowever it is unclear whether these phenomena could be mapped onto human hallucinogenic experiences.
Ultimately, though, the study could mark a vital step toward developing non-hallucinogenic drugs that enhance a patient's neuroplasticity, and hopefully reduce their mental health symptoms.